The Premier Continuum of Care Lunch N' Learn (LNL) December 17, 2025 CE webinar will be held from 1 - 2 pm EST. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
Treatment Considerations for Neuropsychiatric Manifestations of Alzheimer's Disease
SPEAKER: Sunny Linnebur, PharmD, BCGP, BCPS, FCCP, FASCP, Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences,University of Colorado Anschutz Medical Campus, Aurora, CO
ACPE Universal Activity Number: 0122-0000-25-055-L01-P/T [0.1 CEU] [1 Contact Hr.]
Date: Dec 17, 2025 01:00 PM - 02:00 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Dec 17, 2025 01:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists and Pharmacy Technicians
Accreditation(s)
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for CE Credit
CE participation will be provided to CPE Monitor within 45 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.
Support
Financial support: Premier, Inc. has received no outside support for the administration of this program.
Objectives
- Discuss common neuropsychiatric manifestations of Alzheimer's Disease
- Identify FDA-approved options for treating agitation in persons with Alzheimer's Disease
- Outline additional medications that have been investigated for the treatment of agitation and psychosis in persons with Alzheimer's Disease
- Describe toxicities/adverse events associated with medications commonly utilized to treat neuropsychiatric manifestations of Alzheimer's Disease
Activity Number
0122-0000-25-055-L01-P/T
Date:
12/17/25
Time:
01:00 PM - 02:00 PM
CE Hours
1.00